John Peschier | MD, IR |
Terrence Duffy | Executive Chairman & CEO |
Sean Tully | Senior MD and Global Head, Financial & OTC Products |
John Pietrowicz | CFO and Senior MD |
Bryan Durkin | President |
Derek Sammann | Senior MD and Global Head, Commodities & Options Products |
Brian Bedell | Deutsche Bank |
Christopher Allen | Rosenblatt Securities |
Alex Kramm | UBS |
Daniel Fannon | Jefferies LLC |
Michael Carrier | Bank of America Merrill Lynch |
Richard Repetto | Sandler O'Neill + Partners |
Patrick O'Shaughnessy | Raymond James & Associates |
Benjamin Herbert | Citigroup |
Kyle Voigt | KBW |
Kenneth Worthington | JPMorgan Chase & Co. |
Christopher Harris | Wells Fargo Securities |
Alexander Blostein | Goldman Sachs Group |
Brian Bedell | Deutsche Bank AG |
Alex Kramm | UBS Investment Bank |
Jeremy Campbell | Barclays PLC |
Jonathan Casteleyn | Hedgeye Risk Management |
Good day, and welcome to the CME Group Fourth Quarter and Full Year 2017 Earnings Call. At this time, I would like to turn the conference over to Mr. John Peschier. Please go ahead, sir.
Good morning, everyone.